169 related articles for article (PubMed ID: 29098526)
1. Elevated Plasma Level of Soluble Form of RAGE in Ischemic Stroke Patients with Dementia.
Tang SC; Yang KC; Hu CJ; Chiou HY; Wu CC; Jeng JS
Neuromolecular Med; 2017 Dec; 19(4):579-583. PubMed ID: 29098526
[TBL] [Abstract][Full Text] [Related]
2. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).
Lam JK; Wang Y; Shiu SW; Wong Y; Betteridge DJ; Tan KC
Diabet Med; 2013 Jun; 30(6):702-9. PubMed ID: 23432638
[TBL] [Abstract][Full Text] [Related]
3. Cleaved but not endogenous secretory RAGE is associated with outcome in acute ischemic stroke.
Tang SC; Yeh SJ; Tsai LK; Hu CJ; Lien LM; Peng GS; Yang WS; Chiou HY; Jeng JS
Neurology; 2016 Jan; 86(3):270-6. PubMed ID: 26683643
[TBL] [Abstract][Full Text] [Related]
4. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
[TBL] [Abstract][Full Text] [Related]
5. Total soluble and endogenous secretory receptor for advanced glycation endproducts (RAGE) in IBD.
Meijer B; Hoskin T; Ashcroft A; Burgess L; Keenan JI; Falvey J; Gearry RB; Day AS
J Crohns Colitis; 2014 Jun; 8(6):513-20. PubMed ID: 24291021
[TBL] [Abstract][Full Text] [Related]
6. The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation.
Lancefield TF; Patel SK; Freeman M; Velkoska E; Wai B; Srivastava PM; Horrigan M; Farouque O; Burrell LM
PLoS One; 2016; 11(9):e0161715. PubMed ID: 27627677
[TBL] [Abstract][Full Text] [Related]
7. Metabolic dysfunction in Emirati subjects in Abu Dhabi: Relationship to levels of soluble RAGEs.
Abdulle A; Inman CK; Saleh A; Noshi M; Galani D; Abdelwareth L; Alsafar H; Elfatih A; Al Shamsi H; Ali R; Li H; Ramasamy R; Schmidt AM; Benbarka MM; Hassan MH
J Clin Transl Endocrinol; 2019 Jun; 16():100192. PubMed ID: 31080742
[TBL] [Abstract][Full Text] [Related]
8. AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease.
Prasad K; Dhar I; Zhou Q; Elmoselhi H; Shoker M; Shoker A
Mol Cell Biochem; 2016 Dec; 423(1-2):105-114. PubMed ID: 27714575
[TBL] [Abstract][Full Text] [Related]
9. Assessment of EN-RAGE, sRAGE, and its isoforms: cRAGE, esRAGE in obese patients treated by moderate caloric restriction combined with physical activity conducted in hospital condition.
Kanikowska D; Kanikowska A; Strojny Z; Kawka E; Zawada A; Rutkowski R; Litwinowicz M; Sato M; Grzymisławski M; Bręborowicz A; Witowski J; Korybalska K
Cytokine; 2024 Aug; 180():156665. PubMed ID: 38823153
[TBL] [Abstract][Full Text] [Related]
10. Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes.
Lee AC; Lam JK; Shiu SW; Wong Y; Betteridge DJ; Tan KC
PLoS One; 2015; 10(9):e0137330. PubMed ID: 26325204
[TBL] [Abstract][Full Text] [Related]
11. Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort.
Loomis SJ; Chen Y; Sacks DB; Christenson ES; Christenson RH; Rebholz CM; Selvin E
Clin Chem; 2017 May; 63(5):980-989. PubMed ID: 28280052
[TBL] [Abstract][Full Text] [Related]
12. Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes.
Humpert PM; Djuric Z; Kopf S; Rudofsky G; Morcos M; Nawroth PP; Bierhaus A
Cardiovasc Diabetol; 2007 Mar; 6():9. PubMed ID: 17343760
[TBL] [Abstract][Full Text] [Related]
13. Elevated endogenous secretory receptor for advanced glycation end products (esRAGE) levels are associated with circulating soluble RAGE levels in diabetic children.
Saito R; Araki S; Yamamoto Y; Kusuhara K
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):63-69. PubMed ID: 27941172
[TBL] [Abstract][Full Text] [Related]
14. Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy.
Kumar NP; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Hissar S; Kornfeld H; Babu S
BMC Infect Dis; 2019 Dec; 19(1):1039. PubMed ID: 31818258
[TBL] [Abstract][Full Text] [Related]
15. The AGE-RAGE Axis and Its Relationship to Markers of Cardiovascular Disease in Newly Diagnosed Diabetic Patients.
Villegas-Rodríguez ME; Uribarri J; Solorio-Meza SE; Fajardo-Araujo ME; Cai W; Torres-Graciano S; Rangel-Salazar R; Wrobel K; Garay-Sevilla ME
PLoS One; 2016; 11(7):e0159175. PubMed ID: 27434539
[TBL] [Abstract][Full Text] [Related]
16. Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients.
Katakami N; Matsuhisa M; Kaneto H; Matsuoka TA; Sakamoto K; Yasuda T; Yamasaki Y
Diab Vasc Dis Res; 2008 Sep; 5(3):190-7. PubMed ID: 18777492
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia.
Emanuele E; D'Angelo A; Tomaino C; Binetti G; Ghidoni R; Politi P; Bernardi L; Maletta R; Bruni AC; Geroldi D
Arch Neurol; 2005 Nov; 62(11):1734-6. PubMed ID: 16286548
[TBL] [Abstract][Full Text] [Related]
18. Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.
Colhoun HM; Betteridge DJ; Durrington P; Hitman G; Neil A; Livingstone S; Charlton-Menys V; Bao W; Demicco DA; Preston GM; Deshmukh H; Tan K; Fuller JH
Diabetes; 2011 Sep; 60(9):2379-85. PubMed ID: 21771973
[TBL] [Abstract][Full Text] [Related]
19. Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients.
Kalousová M; Jáchymová M; Mestek O; Hodková M; Kazderová M; Tesar V; Zima T
Nephrol Dial Transplant; 2007 Jul; 22(7):2020-6. PubMed ID: 17347281
[TBL] [Abstract][Full Text] [Related]
20. Correlation among soluble receptors for advanced glycation end-products, soluble vascular adhesion protein-1/semicarbazide-sensitive amine oxidase (sVAP-1) and cardiometabolic risk markers in apparently healthy adolescents: a cross-sectional study.
Gurecká R; Koborová I; Csongová M; Šebek J; Šebeková K
Glycoconj J; 2016 Aug; 33(4):599-606. PubMed ID: 27300745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
